Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Devine

Blood

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Blood|December 17, 2011
Can we build a better allograft?Steven M Devine
Blood|September 17, 2016
How do stem cells mobilize? Bridging the GAPSteven M Devine
Blood|September 19, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we canMehdi Hamadani, Steven M Devine
Blood|June 5, 2002
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myelomaSteven M Devine, Balkrishna Jahagirdar, Koen van Besien
Blood|March 26, 2008
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantationMehdi Hamadani, Farrukh T Awan, Steven M Devine
Blood|November 5, 2004
Fatal case of protothecosis in a hematopoietic stem cell transplant recipient after infliximab treatment for graft-versus-host diseaseJad A Khoury, Eric R Dubberke, Steven M Devine
Blood|December 14, 2002
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primatesSteven M Devine, Carrington Cobbs, Matt Jennings, et al.
Blood|August 17, 2006
Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100Rebecca M Shepherd, Benjamin J Capoccia, Steven M Devine, et al.
Blood|May 14, 2005
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF aloneNeal Flomenberg, Steven M Devine, John F Dipersio, et al.
Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Blood|December 17, 2011
Can we build a better allograft?Steven M Devine
Blood|September 17, 2016
How do stem cells mobilize? Bridging the GAPSteven M Devine
Blood|September 19, 2009
Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we canMehdi Hamadani, Steven M Devine
Blood|June 5, 2002
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myelomaSteven M Devine, Balkrishna Jahagirdar, Koen van Besien
Blood|March 26, 2008
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantationMehdi Hamadani, Farrukh T Awan, Steven M Devine
Blood|November 5, 2004
Fatal case of protothecosis in a hematopoietic stem cell transplant recipient after infliximab treatment for graft-versus-host diseaseJad A Khoury, Eric R Dubberke, Steven M Devine
Blood|December 14, 2002
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primatesSteven M Devine, Carrington Cobbs, Matt Jennings, et al.
Blood|August 17, 2006
Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100Rebecca M Shepherd, Benjamin J Capoccia, Steven M Devine, et al.
Blood|May 14, 2005
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF aloneNeal Flomenberg, Steven M Devine, John F Dipersio, et al.
Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.
Pageof 3